A Review of High Content Imagers for 3D Cell Culture Imaging
Visikol published a post in February 2020 titled, “A Review of High Content Imagers for 3D Cell Culture Imaging.” [...]
When will organs on a chip and advanced in vitro systems catch on in drug discovery?
Every week we see a new company or publication describing an advanced in vitro system for replacing the use [...]
Human Pancreas 3D Tissue Imaging Using Visikol HISTO
Mike Johnson2020-01-24T10:46:11-05:00Whenever possible, we try to highlight the great work that our customers are doing in using our tissue clearing [...]
Visikol at Society of Toxicology Booth #663
This year marks Visikol's fifth year attending SOT as an exhibitor and the focus for the company this year [...]
Visikol Expands Headquarters in Move to Hampton, NJ
Mike Johnson2020-01-10T12:34:40-05:00To kick off the new year, Visikol has announced that it has expanded its footprint in New Jersey by [...]
Detecting Tumor Regions Using Convolutional Neural Networks
Mike Johnson2019-12-09T08:18:19-05:00Breast cancer is a serious disease with a wide array of treatment options depending on the severity of the [...]
Barriers to Adopting Machine Learning and Digital Pathology in the Clinic
As a leading provider of digital pathology services and solutions, we have worked with dozens of pharmaceutical companies in [...]
Blog Post: Pre-clinical Ophthalmology Services
Visikol is a contract research organization that provides researchers at academic institutions and pharmaceutical companies with unique services in [...]
Come Visit Visikol at the Liver Meeting in Boston at Booth 331 from Nov 9-11
This year's Liver Meeting will be the 70th annual meeting of the American Association for the Study of Liver Diseases [...]
Visikol Expands Image Analysis as a Service Capabilities
Visikol is one of the leading providers of digital pathology services and partners with researchers to assist them in [...]